Life ScienceCompany
Momenta Pharmaceuticals M&A Summary
Momenta Pharmaceuticals has acquired 2 companies of its own.
Momenta Pharmaceuticals’ largest acquisition to date was in 2011, when it acquired Virdante Pharmaceuticals - Sialic Switch Assets for $5M. Momenta Pharmaceuticals has acquired in 2 different US states. The Company’s most targeted sectors include information services (50%) and life science (50%).
Momenta Pharmaceuticals Ownership
Who owns Momenta Pharmaceuticals?
Momenta Pharmaceuticals is owned by Johnson & Johnson. It was acquired on August 19, 2020.
Momenta Pharmaceuticals Business Overview
Where is Momenta Pharmaceuticals headquartered?
Momenta Pharmaceuticals is headquartered in Cambridge, Massachusetts.
What is Momenta Pharmaceuticals’ revenue?
Momenta Pharmaceuticals disclosed revenue of 24M USD for 2019 and 76M USD for 2018.
How many employees does Momenta Pharmaceuticals have?
Momenta Pharmaceuticals has 131 employees.
What sector is Momenta Pharmaceuticals in?
Momenta Pharmaceuticals is a life science company.
When was Momenta Pharmaceuticals founded?
Momenta Pharmaceuticals was founded in 2001.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
